LABETALOL HCL 200 MG TABLET

Labetalol Hydrochloride
$0.1435per EA

Strength

200 mg/1

Manufacturer

Innogenix, Inc.

NDC

71247012705

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

2/18/2026

Active Ingredients

LABETALOL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA075215

On Market Since

2/8/2021

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price History

1W

0.0%

1M

0.0%

3M

-1.2%

6M

-2.6%

1Y

-3.2%

3Y

-10.7%

5Y

N/A

All

-28.7%